Nymox Announces Phase 3 BPH Studies
April 01, 2015 at 10:00 AM EDT
Nymox Pharmaceutical Corporation (Nasdaq: NYMX) announced today that the Company is undertaking further analyses of its pivotal U.S. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.